首页> 外文OA文献 >Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles
【2h】

Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles

机译:内吞逃脱封装在可生物降解纳米颗粒中的外源抗原后,交叉展示的增强和延长

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

CD8+ T-cell responses are critical in the immunological control of tumours and infectious diseases. To prime CD8+ T cells against these cell-associated antigens, exogenous antigens must be cross-presented by professional antigen-presenting cells (APCs). While cross-presentation of soluble antigens by dendritic cells is detectable in vivo, the efficiency is low, limiting the clinical utility of protein-based vaccinations. To enhance the efficiency of presentation, we generated nanoparticles from a biodegradable polymer, poly(d,l-lactide-co-glycolide) (PLGA), to deliver antigen into the major histocompatibility complex (MHC) class I antigen presentation pathway. In primary mouse bone marrow-derived dendritic cells (BMDCs), the MHC class I presentation of PLGA-encapsulated ovalbumin (OVA) stimulated T cell interleukin-2 secretion at 1000-fold lower concentration than soluble antigen and 10-fold lower than antigen-coated latex beads. The microparticles also served as an intracellular antigen reservoir, leading to sustained MHC class I presentation of OVA for 72 hr, decreasing by only 20% after 96 hr, a time at which the presentation of soluble and latex bead-associated antigens was undetectable. Cytosol extraction demonstrated that antigen delivery via PLGA particles increased the amount of protein that escaped from endosomes into the cytoplasm, thereby increasing the access of exogenous antigen to the classic MHC class I loading pathway. These data indicate that the unique properties of PLGA particle-mediated antigen delivery dramatically enhance and sustain exogenous antigen presentation by MHC class I, potentially facilitating the clinical use of these particles in vaccination.
机译:CD8 + T细胞反应在肿瘤和传染病的免疫控制中至关重要。要针对这些细胞相关抗原引发CD8 + T细胞,必须通过专业抗原呈递细胞(APC)交叉呈递外源抗原。虽然在体内可检测到树突状细胞对可溶性抗原的交叉呈递,但效率低,限制了基于蛋白质的疫苗接种的临床实用性。为了提高提呈效率,我们从可生物降解的聚合物聚(d,l-丙交酯-共-乙交酯)(PLGA)中产生了纳米颗粒,以将抗原递送到主要的组织相容性复合体(MHC)I类抗原提呈途径中。在原代小鼠骨髓源性树突状细胞(BMDC)中,PLGA封装的卵清蛋白(OVA)的MHC I类表现刺激了T细胞白介素2分泌,其浓度比可溶性抗原低1000倍,比抗原低10倍。包衣乳胶珠。微粒还充当细胞内抗原库,导致OVA持续MHC I类呈递持续72小时,而在96小时(可检测到与可溶性和乳胶微珠相关的抗原的呈递时间)后仅下降20%。胞浆提取表明,通过PLGA颗粒进行的抗原递送增加了从内体逃逸到细胞质中的蛋白质数量,从而增加了外源抗原进入经典的MHC I类负载途径的途径。这些数据表明,PLGA颗粒介导的抗原传递的独特性质显着增强并维持了MHC I类的外源抗原呈递,从而潜在地促进了这些颗粒在疫苗接种中的临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号